James P. Howe

     Attorney At  Law   

36 South County Commons Way C6     

Wakefield, RI 02879    
(401) 788-0600    





















       Rhode Island Fen Phen, Redux & Pondimin

 The common use of Fen-Phen diet drugs Redux and Pondimin have led to an unprecedented number of new Primary Pulmonary Hypertension (PPH) cases over the last 10 years. The FDA removed these popular diet drugs from the marketplace in 1997 because of links to Primary Pulmonary Hypertension and other heart conditions such as mistral and aortic valve regurgitation.

The following medical conditions are consistent with conditions caused by   Fen Phen,  Redux or Pondimin:


  • Symptoms of Primary Pulmonary Hypertension

  • Progressive shortness of breath with activity

  • Hyperventilation

  • Chest pain under the sternum

  • Weakness

  • Fatigue

  • Fainting

  • Lightheadedness with upright posture

  • Dizziness

  • Coughing up blood

Pulmonary hypertension develops as a response to increased resistance to blood flow. Diffuse narrowing of the pulmonary arterioles occurs. The right side of the heart becomes enlarged due to the increased work load of pumping blood against this resistance. Eventually, progressive heart failure develops.

Fen phen was a combination drug mixture of Pondimin or Redux with phentermine (an amphetamine-like drug) and was designed to promote weight loss. Both Redux (dexfenfluramine) and Pondimin (fenfluramine), the "Fen"s in the combination, were diet drugs manufactured by American Home Products ("AHP"). They were designed to suppress the appetite by altering brain levels of serotonin, but both were withdrawn simultaneously from the market in September of 1997 when both were linked to the occurrence of serious cardiac valvular disease, and primary pulmonary hypertension

Pondimin and Redux were two of the most widely prescribed diet drugs in the U.S. In 1996, sales of Pondimin and Redux totaled well over 20 million prescriptions. According to company estimates, 4 million people have used Pondimin and another 2 million have used Redux.

The Law Offices of James P. Howe is a Rhode Island Medical Malpractice Law Firm who commits the necessary resources to fight any pharmaceutical corporation including the manufacturers of Fen Phen, Redux and Pondimen and all other diet drugs.


We work on a contingency fee basis. A contingency fee means we only obtain a fee if we make a recovery. If we do not win the case or make a recovery our clients owe us nothing for our time, costs or expenses.

With many decades of combined experience, the Law Offices of James P. Howe, and our highly experienced staff of trial attorneys, paralegals, investigators and law clerks have the expertise and ample resources to successfully research, investigate and litigate all of our clients Primary Pulmonary Hypertension claims. We promise every client that their claim will be reviewed diligently and carefully. If we take a case, we will work extremely hard to obtain the best possible result. We can help you immediately. All e-mail and form submissions will be responded to by a qualified member of our firm within 24 hours.


Contact us today by Email or call us today at  (401) 788-0600 to speak with someone from our  firm..



James P. Howe Law Offices
36 South County Commons Way C6, Wakefield RI 02879
Phone : (401) 788-0600   Fax: (401) 788-0605

This Site is designed and hosted by HanlonAssoc®, a service of Kevin L. Hanlon & Associates, Inc.